Literature DB >> 20424964

Myocardial ischemia in patients with diastolic dysfunction and heart failure.

Thomas E Vanhecke1, Robert Kim, Shaheena Z Raheem, Peter A McCullough.   

Abstract

Coronary artery disease is present in 40-55% of patients with diastolic heart failure, and myocardial ischemia is both a cause and a precipitant of diastolic heart failure. Failure to recognize and treat acute and chronic ischemia in patients with this disorder results in rapid disease progression and poor outcomes. In diastolic heart failure patients without obstructive coronary artery disease, ischemia can be induced by other diseases that diminish perfusion gradient, cause myocardium to outgrow blood supply, or decrease diastolic filling time. In this article, we review the role of ischemia and development of fibrosis in the epidemiology, pathophysiology, and evaluation of patients with diastolic dysfunction and diastolic heart failure.

Entities:  

Mesh：

Year:  2010        PMID： 20424964     DOI： 10.1007/s11886-010-0101-1

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  50 in total

1.  Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.

Authors:  M Peltier; D Houpe; A Cohen-Solal; M Béguin; F Levy; C Tribouilloy
Journal:  Int J Cardiol       Date:  2006-10-16       Impact factor: 4.164

2.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

3.  Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Evan Appelbaum; Caitlin J Harrigan; Jacki Buros; C Michael Gibson; Connie Hanna; John R Lesser; James E Udelson; Warren J Manning; Barry J Maron
Journal:  Circ Heart Fail       Date:  2008-06-23       Impact factor: 8.790

Review 4.  New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment.

Authors:  Michael R Zile; Dirk L Brutsaert
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

5.  Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.

Authors:  Heather Fraser; Luiz Belardinelli; Lianguo Wang; Peter E Light; Jeffrey J McVeigh; Alexander S Clanachan
Journal:  J Mol Cell Cardiol       Date:  2006-10-05       Impact factor: 5.000

6.  Adenosine provokes diastolic dysfunction in microvascular angina.

Authors:  D Vinereanu; A G Fraser; M Robinson; A Lee; A Tweddel
Journal:  Postgrad Med J       Date:  2002-01       Impact factor: 2.401

7.  Outcome of heart failure with preserved ejection fraction in a population-based study.

Authors:  R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

8.  Persistent diastolic dysfunction despite complete systolic functional recovery after reperfused acute myocardial infarction demonstrated by tagged magnetic resonance imaging.

Authors:  Clerio F Azevedo; Luciano C Amado; Dara L Kraitchman; Bernhard L Gerber; Nael F Osman; Carlos E Rochitte; Thor Edvardsen; Joao A C Lima
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

9.  Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy.

Authors:  N Yoshida; H Ikeda; T Wada; A Matsumoto; S Maki; A Muro; A Shibata; T Imaizumi
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

10.  Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Iacopo Olivotto; Franco Cecchi; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Francesca Girolami; Francesca Torricelli; Paolo G Camici
Journal:  J Am Coll Cardiol       Date:  2006-03-07       Impact factor: 24.094
View more
  10 in total

Review 1.  Novel paradigms in the therapeutic management of heart failure with preserved ejection fraction: clinical perspectives.

Authors:  Fayez El Shear
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

2.  Heart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic Enigma.

Authors:  Taslima Bhuiyan; Mathew S Maurer
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-10

Review 3.  [Catecholamines: pro and contra].

Authors:  R Riessen; O Tschritter; U Janssens; M Haap
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-03-25       Impact factor: 0.840

4.  Diastolic function in patients with heart failure with preserved ejection fraction and atrial fibrillation: impact of diabetes.

Authors:  Ruxandra-Nicoleta Horodinschi; Camelia Cristina Diaconu
Journal:  Am J Cardiovasc Dis       Date:  2021-10-25

5.  MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction.

Authors:  JaBaris D Swain; Anthony S Fargnoli; Michael G Katz; Catherine E Tomasulo; Marina Sumaroka; Kyle C Richardville; Walter J Koch; Joseph E Rabinowitz; Charles R Bridges
Journal:  J Cardiovasc Transl Res       Date:  2012-12-01       Impact factor: 4.132

6.  Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia.

Authors:  R Maharaj
Journal:  J Saudi Heart Assoc       Date:  2012-02-01

Review 7.  Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?

Authors:  Jia Li; Peter Moritz Becher; Stefan Blankenberg; Dirk Westermann
Journal:  Cardiol Res Pract       Date:  2013-10-24       Impact factor: 1.866

8.  Correlation Between Diastolic Dysfunction and Coronary Artery Disease on Coronary Computed Tomography Angiography.

Authors:  Abdelrahman Jamiel; Amjad M Ahmed; Iyad Farah; Mouaz H Al-Mallah
Journal:  Heart Views       Date:  2016 Jan-Mar

9.  Pulmonary Edema and Diastolic Heart Failure in the Perioperative Period.

Authors:  Galen Royce-Nagel; Kunal Karamchandani
Journal:  Case Rep Anesthesiol       Date:  2018-01-23

10.  Postoperative pulmonary edema following vitrectomy in patients with ischemic heart disease and diastolic dysfunction in the post-anesthetic care unit: Two case reports.

Authors:  Yuseon Cheong; Namyoong Kim; Minsoo Kim; Hee-Jeong Son; Jin Huh; Seong-Sik Kang; So Young Lim; Byeongmun Hwang
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.